Arformoterol Tartrate Suppliers & Bulk Manufacturers
Available Forms: solution for inhalation
Available Strengths: 15 mcg per 2 mL
Reference Brands: Brovana (USA/EU)
Category:
Respiratory Disorder
Arformoterol (Brovana) is a long-acting beta-2 adrenergic agonist (LABA) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways, leading to improved airflow and easier breathing. Arformoterol is administered via a nebulizer as a sterile solution, typically dosed at 15 mcg per 2 mL.
Arformoterol Tartrate is available in solution for inhalation
and strengths such as 15 mcg per 2 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Arformoterol Tartrate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Arformoterol Tartrate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Arformoterol tartrate is a long-acting bronchodilator used primarily for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It belongs to the class of long-acting beta-2 adrenergic agonists (LABAs) and works by selectively stimulating beta-2 receptors in the airway smooth muscles. This action leads to prolonged relaxation of the bronchial muscles, resulting in improved airflow and easier breathing. Arformoterol is the (R,R)-enantiomer of formoterol, which provides targeted bronchodilation with sustained efficacy. It is typically administered via nebulization, making it especially suitable for patients who have difficulty using inhalers. The medication is not intended for the relief of acute bronchospasm but is used as a regular maintenance therapy to reduce symptoms such as wheezing, shortness of breath, and chest tightness. Its long duration of action allows for twice-daily dosing, improving patient compliance and overall disease management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing